chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ACUTE HYPERCAPNIC RESPIRATORY FAILURE 6/10/2021 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 6/21/2021 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 6/21/2021 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/16/2021 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/10/2021 HYPOXEMIA 5/24/2021 ACUTE HYPERCAPNIC RESPIRATORY FAILURE 6/10/2021    CHRONIC HYPOXEMIC RESPIRATORY FAILURE 6/21/2021    CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 6/21/2021    RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/16/2021    HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/10/2021    HYPOXEMIA 5/24/2021    ACUTE HYPERCAPNIC RESPIRATORY FAILURE 6/10/2021 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 6/21/2021 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 6/21/2021 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/16/2021 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/10/2021 HYPOXEMIA 5/24/2021
Headache, Myalgia, Fever & NauseaVomiting Narrative:  Employee missed 2 days of work due to chills, headache, nausea, vomiting and temperature up to 100.7. Currently has headache. Plans to return to work tomorrow.
3-4 hours after vaccination, client had elevated temperature of 103-104 degrees F and feeling of being hot then cold.  Splotchy rash with "swollen feet" lasting approximately 2 days.  Symptoms resolved without treatment.  Client not seen by physician.
Severe aches and chills 5/16/21-5/17/21. Responses below tie to these reactions and not the more concerning downstream event of note.  Of note: Unexplained stroke occurred 5/31/21. Please contact me if this is to be explored.
Narrative:  COVID infection following COVID vaccine series 06/18, Pfizer, dose #1 07/09, Pfizer, dose #2 12/22 SARS-COV-2 Variant Sequencing: pending 12/22 BNP: 715.7 12/22 COVID swab, result: detected 12/22 pt cc: dry cough, anorexia, exertional intolerance exposure: unknown 12/22 pt admit to ED, cc: dry  cough, anorexia, exertional intolerance dx: Acute on Chronic Heart Failure exacerbation Covid infection Chronic anemia LOS: 5 12/22 CXR impression:  Since 7/20/2021, mildly improved aeration of the lungs. However, there is  persistent diffuse bilateral interstitial opacities as well as left perihilar/basilar focal consolidation. This may represent a combination of left pleural effusion and  atelectasis and appears chronic, but is nonspecific. Mild pulmonary edema. 12/22 FIBRINOGEN: 447 12/22 DDIMER: 6.56 12/22 CRP: 5.951 12/23 FIBRINOGEN: 517 12/23 DDIMER: 5.07 12/23 ESR: 47 12/24 FIBRINOGEN: 447 12/24 DDIMER: 4/27 12/24 ESR: 42 12/25 FIBRINOGEN: 415 12/25 DDIMER: 4.58 12/25 ESR: 102 12/26 FIBRINOGEN: 369 12/26 DDIMER: 4.12 12/26 ESR: 73 12/27 FIBRINOGEN: 387 12/27 DDIMER: 4.17 12/27 ESR: 83
This spontaneous case reported by a consumer, describes the occurrence of myalgia (sore arm), chills, myalgia (muscle pain), pyrexia (fever) and fatigue in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Feb 23, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced myalgia (sore arm), chills, myalgia (muscle pain), pyrexia (fever), fatigue and headache. At the time of the report, myalgia (sore arm) resolved; chills, pyrexia (fever) and fatigue outcome: unknown; myalgia (muscle pain): resolving; and headache: not resolved. Concomitant medication and treatment information not reported.
01/12/2021  12:00 P.M. started feeling tired and legs were hurting. Got worse in the next 4 hours. Around 4:00 P.M left work body ached so bad could hardly lift legs into car. By 6:PM ran a 100° Temp and head ache and bad body aches. By morning 01/13/2021 felt fine.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 71-year-old female patient. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported. On or about 05-DEC-2008, the patient was vaccinated with ZOSTAVAX (dose, route of administration, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient was treated by a physician for ophthalmic herpes zoster. The outcome of ophthalmic herpes zoster was unknown. The reporter considered ophthalmic herpes zoster to be related to ZOSTAVAX. Upon internal review, the event of ophthalmic herpes zoster was considered to be medically significant. Additional information has been requested.
white area around site w/violaceous boarder which began 11 days p/vax;very swollen edematous legs;no pain, no fever;sed rate 5, nl CBC;
Just extreme arm pain four hours following the injection. It lasted through till today, but the first 36 hours were really painful. And on the opposite arm it was starting to get painful in the same area of the injection. Lifting my arm causes more pain.
Diagnosed with Ranaud's, first episode a few days after 1st Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of RAYNAUD'S PHENOMENON (Diagnosed with Ranaud's, first episode a few days after 1st Moderna vaccine) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient had allergy with unknown drug.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RAYNAUD'S PHENOMENON (Diagnosed with Ranaud's, first episode a few days after 1st Moderna vaccine). At the time of the report, RAYNAUD'S PHENOMENON (Diagnosed with Ranaud's, last episode a few days after 1st Moderna vaccine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medication was not reported.  Patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment.  Patient received second dose of Moderna on 26-Mar-2021, Batch/Lot No: 04621A. Patient received Paxlovid form 28-Oct-2022 to 29-Oct-2022 for COVID-19 treatment. After taking Paxlovid throat began to swell, could not swallow, or talk and became dehydrated. Patient took off after 3 courses, 1and 1/2 days, and could not get in touch with physician. Patient was started to be able to swallow within about 6 hours of discontinuing which was recovered. Treatment details were not reported.
Throbbing/painful arm, fatigue, felt cold, body physically shaking "felt out of it". Pt. went to ER and was told to take Benadryl/ibuprofen every 6 hours.
Information has been received from a registered nurse concerning a child who was vaccinated with varicella virus vaccine live. Subsequently, the patient developed chicken pox. Unspecified medical attention was sought. There was no product quality complaint involved. Follow up information indicated that this was not a reaction. No further information is expected.
pt had a large red area that was warm to touch on lt thigh;advised to use ibuprofen every 6 hours & ice several times a day;
Had fever of 101 degrees 4-23-12 in the evening. Gave TYLENOL. Fever 104 on 4-24-12 at 0430. Took to ER. No cough. No foul urine. No rash. No rhinorrhea. No vomiting/diarrhea. CXR = no obvious infiltrate.
Full body itch, treated with Benadryl ten minutes post vaccination. Stomach cramps, 4 hour post vaccine. Fever, chills, muscle aches
patient fell and hit her head. Her head started bleeding; patient fell and hit her head. Her head started bleeding; did feel dizzy that she just tripped; Initial information was received on 13-Nov-2020 regarding an unsolicited valid non-serious case from a pharmacist.  This case involves a 86-year-old female patient who was fell and hit her head her head started bleeding (fall and head injury) and did feel dizzy that she just tripped (dizziness)and did feel dizzy that she just tripped (dizziness), while she received vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  Medical history, concomitant medication, past medical treatment(s), vaccination(s) and family history were not provided. It was reported that the patient did not received any other vaccines on that day.  On 13-Nov-2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ517AA, expiry date 30-Jun-2021) via intramuscular route in the left arm for prophylactic vaccination.  On 13-Nov-2020, the patient developed non-serious fell and hit her head, her head started bleeding (fall and head injury) and did feel dizzy that she just tripped (dizziness) on the same day following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. It was reported that the patient did not faint.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  The outcome was unknown for all the events at the time of reporting.
This spontaneous report as received from a 64 year old female patient via a company representative regarding herself. On 2016, the patient was vaccinated with ZOSTAVAX, subcutaneous for prophylaxis. On an unknown date, the patient's arm at the site swelled to the size of a baseball(vaccination site swelling and vaccination site mass). The outcome of vaccination site mass and vaccination site swelling was reported as recovered. Causality assessment was not provided. Additional information is not expected as no contact details have been provided.
Patient presented to the ER on 10/26/17 complaining of left arm pain and redness after receiving FLUARIX on 10/24/17. She was noted to have an 8 cm area of redness. She was diagnosed with cellulitis of the left arm in the ER.
pt recv vax 7PM & was due for APAP & feeding, stopped breathing x 1min per mom;turned pale & lips purple;began breathing spontaneously w/stimulation;911 called, seen in ER adm to hosp t100.9;
Felt very tired for 3 days after shot. But no rash.  But  7 days later, developed a baseball size red circular rash on the injection site on my right arm. Very itchy, feels like there is a lump, around that area.  Sore, itchy. I have had the red rash for 3 days already.  I have put some cortisone cream on it to try to relieve the itch, and also use a warm, wet compress over the site twice a day to try to get some relief. Redness and size of area affected has not diminished. If this doesn't diminish in a day or two more, will need to call my doctor to see what can be done.
Chills, later followed by reduced appetite, followed by nausea without vomiting, slight diarrhea. About 18 hours post injection, fatigue was so severe that I had to leave work and go home to sleep. I slept most of the 60 hours following the injection. I think I am okay now. It is 69 hours post injection. I also received an influenza injection during the same office visit.  P.S. I'm taking pathophysiology and pharmacology right now - I start nursing school next year.
pt devel elevated WBC & low grade fever p/rabies shot; pt was checked by MD & had no Gyn infections; MD felt pts diabetes was in control & sx came from Rabies shots;
Fever to 110.4, Chills w/ rigors, Myalgias and Joint Pains
This initial spontaneous case, was received from other health professional (nurse) on 06-Nov-2017, concerning a patient of unspecified gender and age. This case refers to 01 out of 18 reports. The patient's medical history and concomitant medications were not reported. It was reported that most of the patients received the vaccine on 09-Oct-17 (as reported), the patient was administered with FLUVIRIN (dose, route of administration, anatomical location, batch number, expiry date: not reported) (explicitly coded to expired vaccine used). It was reported that, the patient had no reaction/had not experienced any adverse event after vaccination. The reporter assessed the events as non-serious.
Patient was hyperventilating before vaccine was administered. After vaccine was administered patient started to get dizzy and skin color changed. Patient lay down, vitals were being taken, and water was given. once patient smelled ammonia patient started feeling better.  Patient stayed for 15 minutes to ensure he was stable to go home.
elevated Blood Pressure 154/104, Heart Rate 57; arm numbness/tingling, arm cold to touch
Arm was a little sore after injection but exploded into searing stabbing pain at the 2 week mark.  The pinpoint soreness was vague and lingering until the middle of the night last night when the intense pain woke me from my sleep.  It isn't bursa pain it is deltoid pain more intense than I ever imagined it could be especially at the two week mark post vaccine!! It is pretty terrible.
Day of shot- left upper arm sore lasted three days. -5 hrs later hoarseness lasted about one hour or so Day after - fatigue Second day 2 1/2 days approx. diahrea
Suspected vaccination failure; Meningitis; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced vaccination failure (serious criteria GSK medically significant) and meningitis (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and meningitis were unknown.   It was unknown if the reporter considered the vaccination failure and meningitis to be related to Bexsero.  Additional information was provided as follows: The age at vaccination was not reported. The patient received Bexsero and still got meningitis. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting.
Initial and follow-up information has been received from a licensed practical nurse concerning a 74 year old female with hypothyroidism and diverticulitis, with no illness at the time of the vaccination and no drug reactions/allergies who on 27-MAR-2008 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot# 659010/1537U) 0.5 mL IM in the right deltoid. Concomitant medication included homeopathic medications (unspecified), levothyroxine sodium (SYNTHROID) and omeprazole (PRILOSEC). The nurse reported that on 28-MAR-2008 the patient developed a swollen arm at the injection site. The patient had no record of previous vaccination with pneumococcal 23v polysaccharide vaccine. The patient applied heat to the site. The onset of the adverse event was 27-MAR-2008 at 10:30AM. On Saturday 29-MAR-2008 the patient's injection site arm turned black, was swollen and painful. On 01-APR-2008 the patient sought unspecified medical attention. On 01-APR-2008 the injection site arm was better but not recovered. At the time of reporting the patient was recovered on an unspecified date. There was no other information to report. Additional information is not expected.
This spontaneous report was received from a doctor of pharmacy refers to a patient of unknown age and gender. On 05-NOV-2012 (reported as 2 days ago) the patient was vaccinated with ZOSTAVAX (lot#, expiration date and route not reported). No concomitant medication were reported. The patient came back to the pharmacy with a prescription for MEDROL DOSEPACK to treat an unspecified condition on 07-NOV-2012. Outcome of the event was unknown. Additional information is not expected.
dry heaves; sweating a lot; nasal congestion; weakness; no appetite; I feel beat up; chills; nausea; my arm was swollen at the injection site; my arm was sore at the injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (dry heaves), HYPERHIDROSIS (sweating a lot), NASAL CONGESTION (nasal congestion), ASTHENIA (weakness) and DECREASED APPETITE (no appetite) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced RETCHING (dry heaves), HYPERHIDROSIS (sweating a lot), NASAL CONGESTION (nasal congestion), ASTHENIA (weakness), DECREASED APPETITE (no appetite), FEELING ABNORMAL (I feel beat up), CHILLS (chills), NAUSEA (nausea), VACCINATION SITE SWELLING (my arm was swollen at the injection site) and VACCINATION SITE PAIN (my arm was sore at the injection site). 20-Apr-2021, the patient experienced HEADACHE (headache). At the time of the report, RETCHING (dry heaves), HYPERHIDROSIS (sweating a lot), NASAL CONGESTION (nasal congestion), ASTHENIA (weakness), DECREASED APPETITE (no appetite), FEELING ABNORMAL (I feel beat up), CHILLS (chills), NAUSEA (nausea), VACCINATION SITE SWELLING (my arm was swollen at the injection site), VACCINATION SITE PAIN (my arm was sore at the injection site) and HEADACHE (headache) outcome was unknown.            Patient took ginger ale to help with the nausea. No relevant concomitant medications were provided.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-083202 (Patient Link).
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history and current conditions were not provided. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL (lot #, expiration date, dose and route were not reported). Secondary suspects and concomitant therapies were not reported. No adverse effects reported. This is one of several reports received from the same reporter. Additional information is not expected due to no consent to contact Health Care Professional was given.
weak feeling; heartbeat climb up and up; unnerving; This is a spontaneous report from a contactable consumer (patient). This 77-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EN5318; expiration date 31May2021) via an unspecified route of administration on 05Feb2021 at 11:30 (at the age of 77-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included high blood pressure and high cholesterol. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications included losartan, escitalopram, and atorvastatin from unknown dates for unspecified indications. The patient received dose 1 of BNT162B2 (lot number EL1284; left arm) on 15Jan2021 at 11:00. The patient previously received codeine on an unknown date for an unknown indication and experienced allergy. On 06Feb2021 at 13:00 the patient experienced a weak feeling and heartbeat climb up. The patient had a weak feeling, had to sit down and took her pulse with oximeter and her Apple watch. She watched her heartbeat climb up and up. She tried yoga breathing but could not slow it down. She was not sure how long this went on because it was very unnerving, but it reached as high as 105 before it started to go down. The beats went up, then down, finally started to keep going down. Once more there was a wave of the weakness through her before she stayed in the 73+ range. The patient was usually in the 60's. Since then the patient's heartbeats have been what is usual for her. During the episode the patient's husband found "rapid heartbeat" on the paper they received. The patient was concerned this happened a day after the vaccine, not within an hour. The events were reported as non-serious. The patient was not hospitalized and did not receive any treatment for the events. The outcomes of weak feeling and rapid heartbeat were recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
This case was reported by a nurse and described the occurrence of incorrect storage of drug in a patient who received PEDIARIX (batch number LK94M, expiry date 5th September 2015), (batch number 4233k, expiry date 5th September 2016) and (batch number 43GM4, expiry date 30th August 2016). On an unknown date, the patient received PEDIARIX. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, an unknown time after receiving PEDIARIX, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional information received: Nurse at this time did not have any other information.  Patients received PEDIARIX that was exposed to temperature of 30.4F Three Lot Numbers LK94M exp 9/5/2015, 4233K exp 9/5/2016; 43GM4 exp 8/30/2016. This case is one of the 6 cases reported by the same reporter for the same vaccine.
Information has been received from a physician concerning a 13 year old female was was vaccinated with GARDASIL vaccine (yeast) (route not reported). On approximately 30-OCT-2007 (also reported as "sometime this week"), the patient got her dose of GARDASIL vaccine (yeast) and had seizures immediately following the injection. The seizures lasted for a couple of seconds and the patient was fine afterwards. As of 30-OCT-2007, the patient had recovered from the seizures. Additional information has been requested.